Client-specific scope reductions in life sciences
A large life sciences client abruptly reduced scope, causing revenue decline. Recovery depends on client's future investment decisions.
TCS / Q2-FY25 / risks
Keep the risk register visible.
TCS · Material risks, their source context, and severity in the latest available quarter.
Research layer active
ConCallIQ research layer
Signal, with the source still visible.
Use the controls below to narrow the view, then follow the evidence into the next layer of context.
Risk intelligence
Material risks this quarter
high
Prolonged weakness in telecom and manufacturing
Telecom and manufacturing verticals face structural headwinds; telecom due to CapEx caution, manufacturing due to labor and supply chain issues.
BSNL deal tapering could create revenue gap
The BSNL deal revenue is at peak and expected to taper after Q3, potentially creating a growth headwind in H2.
Margin pressure from growth market investments
Growth markets have lower margins; scaling them may pressure overall margins until volumes improve.